Paper2822019
Role of fructose 2,6-bisphosphate in the control of glycolysis in mammalian tissues.
Hue L and 1 other. Biochem J, 1987. Cited by 366 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Role of fructose 2,6-bisphosphate in the control of glycolysis in mammalian tissues. Papers, record 2822019. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2822019
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Fructosediphosphates | Major topic |
| Glycolysis | Major topic |
| Hexosediphosphates | Major topic |
| Mammals | Major topic |
| Animals | |
| Liver | |
| Phosphofructokinase-2 | |
| Phosphoric Monoester Hydrolases | |
| Phosphorylation | |
| Tissue Distribution |
Source PubMed
References166
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 6,688,419 | The interaction of fructose 2,6-bisphosphate and AMP with rat hepatic fructose 1,6-bisphosphatase. | J Biol Chem | 1983 | https://conductscience.org/library/papers/6688419 | PubMed |
| 2 | 6,260,770 | Inhibition of fructose-1,6-bisphosphatase by fructose 2,6-bisphosphate. | J Biol Chem | 1981 | https://conductscience.org/library/papers/6260770 | PubMed |
| 3 | 6,453,589 | Fructose 2,6-bisphosphate, the probably structure of the glucose- and glucagon-sensitive stimulator of phosphofructokinase. | Biochem J | 1980 | https://conductscience.org/library/papers/6453589 | PubMed |
| 4 | 319,362 | Enzymology of cancer cells (first of two parts). | N Engl J Med | 1977 | https://conductscience.org/library/papers/319362 | PubMed |
| 5 | 3,021,137 | Effect of tolbutamide on fructose-6-phosphate,2-kinase and fructose-2,6-bisphosphatase in rat liver. | Biochem Biophys Res Commun | 1986 | https://conductscience.org/library/papers/3021137 | PubMed |
| 6 | 6,092,364 | Effect of sulfhydryl modification on the activities of rat liver 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase. | J Biol Chem | 1984 | https://conductscience.org/library/papers/6092364 | PubMed |
| 7 | 2,997,199 | Fructose-1,6-bisphosphatase from rat liver. A comparison of the kinetics of the unphosphorylated enzyme and the enzyme phosphorylated by cyclic AMP-dependent protein kinase. | J Biol Chem | 1985 | https://conductscience.org/library/papers/2997199 | PubMed |
| 8 | 4,830,198 | A linear steady-state treatment of enzymatic chains. General properties, control and effector strength. | Eur J Biochem | 1974 | https://conductscience.org/library/papers/4830198 | PubMed |
| 9 | 6,392,338 | The glucose paradox. Is glucose a substrate for liver metabolism? | J Clin Invest | 1984 | https://conductscience.org/library/papers/6392338 | PubMed |
| 10 | 3,010,981 | Effects of diabetes on fructose 2, 6-P2, glucose 1, 6-P2 and 6-phosphofructo 2-kinase in rat liver. | Biochem Biophys Res Commun | 1986 | https://conductscience.org/library/papers/3010981 | PubMed |
| 11 | 6,096,384 | Rat liver 6-phosphofructo 2-kinase/fructose 2,6-bisphosphatase: a review of relationships between the two activities of the enzyme. | J Cell Biochem | 1984 | https://conductscience.org/library/papers/6096384 | PubMed |
| 12 | 6,311,081 | Gluconeogenesis and related aspects of glycolysis. | Annu Rev Biochem | 1983 | https://conductscience.org/library/papers/6311081 | PubMed |
| 13 | 6,453,588 | Control of the fructose-6-phosphate/fructose 1,6-bisphosphate cycle in isolated hepatocytes by glucose and glucagon. Role of a low-molecular-weight stimulator of phosphofructokinase. | Biochem J | 1980 | https://conductscience.org/library/papers/6453588 | PubMed |
| 14 | 153,704 | Phosphofructokinase. | Adv Enzymol Relat Areas Mol Biol | 1979 | https://conductscience.org/library/papers/153704 | PubMed |
| 15 | 6,092,081 | The protein phosphatases involved in cellular regulation. Glycolysis, gluconeogenesis and aromatic amino acid breakdown in rat liver. | Eur J Biochem | 1984 | https://conductscience.org/library/papers/6092081 | PubMed |
| 16 | 6,301,824 | The protein phosphatases involved in cellular regulation. 1. Classification and substrate specificities. | Eur J Biochem | 1983 | https://conductscience.org/library/papers/6301824 | PubMed |
| 17 | 3,004,827 | Fructose 2,6-bisphosphate and enzymatic activities for its metabolism in ascites tumor. | Curr Top Cell Regul | 1985 | https://conductscience.org/library/papers/3004827 | PubMed |
| 18 | 6,688,179 | Perinatal changes of fructose 2,6-bisphosphate in the rat liver. | Biochem Biophys Res Commun | 1983 | https://conductscience.org/library/papers/6688179 | PubMed |
| 19 | 3,019,688 | Purification and properties of phosphofructokinase 2/fructose 2,6-bisphosphatase from chicken liver and from pigeon muscle. | Eur J Biochem | 1986 | https://conductscience.org/library/papers/3019688 | PubMed |
| 20 | 6,451,625 | Fructose 2,6-bisphosphate. A new activator of phosphofructokinase. | J Biol Chem | 1981 | https://conductscience.org/library/papers/6451625 | PubMed |
Cited by104
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 366 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42,751,120 | Metabolic reprogramming in colorectal cancer: Mechanisms and therapeutic insights. | Genes Dis | 2027 | https://conductscience.org/library/papers/42751120 | PubMed |
| 40,454,774 | Neural Metabolic Networks: Key Elements of Healthy Brain Function. | J Neurochem | 2025 | https://conductscience.org/library/papers/40454774 | PubMed |
| 39,318,551 | Pathogenic role of PFKFB3 in endothelial inflammatory diseases. | Front Mol Biosci | 2024 | https://conductscience.org/library/papers/39318551 | PubMed |
| 38,964,783 | Genetically engineering glycolysis in T cells increases their antitumor function. | J Immunother Cancer | 2024 | https://conductscience.org/library/papers/38964783 | PubMed |
| 38,206,915 | Ameliorating the impairment of glucose utilization in a high-fat diet-induced obesity model through the consumption of Tucum-do-Cerrado (Bactris Setosa Mart.). | PLoS One | 2024 | https://conductscience.org/library/papers/38206915 | PubMed |
| 37,958,470 | PI3K/Akt/mTOR Signaling Pathway in Blood Malignancies-New Therapeutic Possibilities. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37958470 | PubMed |
| 37,534,142 | Increased cardiac PFK-2 protects against high-fat diet-induced cardiomyopathy and mediates beneficial systemic metabolic effects. | iScience | 2023 | https://conductscience.org/library/papers/37534142 | PubMed |
| 36,712,976 | Immunometabolic factors contributing to obesity-linked hepatocellular carcinoma. | Front Cell Dev Biol | 2022 | https://conductscience.org/library/papers/36712976 | PubMed |
| 36,625,925 | Autologous blood transfusion impedes glycolysis in macrophages to inhibit red blood cell injury in type 2 diabetes through PI3K/Akt/PKM2 signaling axis. | Acta Diabetol | 2023 | https://conductscience.org/library/papers/36625925 | PubMed |
| 35,879,299 | Beyond controlling cell size: functional analyses of S6K in tumorigenesis. | Cell Death Dis | 2022 | https://conductscience.org/library/papers/35879299 | PubMed |
| 35,289,743 | Octopamine drives honeybee thermogenesis. | Elife | 2022 | https://conductscience.org/library/papers/35289743 | PubMed |
| 35,140,684 | Identification of Key LncRNAs and Pathways in Prediabetes and Type 2 Diabetes Mellitus for Hypertriglyceridemia Patients Based on Weighted Gene Co-Expression Network Analysis. | Front Endocrinol (Lausanne) | 2021 | https://conductscience.org/library/papers/35140684 | PubMed |
| 35,056,904 | Current Status of the Use of Multifunctional Enzymes as Anti-Cancer Drug Targets. | Pharmaceutics | 2021 | https://conductscience.org/library/papers/35056904 | PubMed |
| 33,673,114 | Cardiometabolism as an Interlocking Puzzle between the Healthy and Diseased Heart: New Frontiers in Therapeutic Applications. | J Clin Med | 2021 | https://conductscience.org/library/papers/33673114 | PubMed |
| 32,911,833 | Signalling, Metabolic Pathways and Iron Homeostasis in Endothelial Cells in Health, Atherosclerosis and Alzheimer's Disease. | Cells | 2020 | https://conductscience.org/library/papers/32911833 | PubMed |
| 31,991,105 | Metabolic Control over mTOR-Dependent Diapause-like State. | Dev Cell | 2020 | https://conductscience.org/library/papers/31991105 | PubMed |
| 31,686,003 | The PI3K-AKT network at the interface of oncogenic signalling and cancer metabolism. | Nat Rev Cancer | 2020 | https://conductscience.org/library/papers/31686003 | PubMed |
| 31,413,316 | Autophagy inhibition elicits emergence from metastatic dormancy by inducing and stabilizing Pfkfb3 expression. | Nat Commun | 2019 | https://conductscience.org/library/papers/31413316 | PubMed |
| 31,308,477 | Inferring novel genes related to colorectal cancer via random walk with restart algorithm. | Gene Ther | 2019 | https://conductscience.org/library/papers/31308477 | PubMed |
| 31,185,774 | Glucose Metabolism in Cardiac Hypertrophy and Heart Failure. | J Am Heart Assoc | 2019 | https://conductscience.org/library/papers/31185774 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2822019
GET https://conductscience.org/api/papers/v1/2822019/references?page=2